Stock Market & Financial Investment News

News Breaks March 22, 2013 08:33 EDT ARIA CHMP adopts positive opinion on ARIAD's Iclusig The EMA's Committee for Medicinal Products for Human Use adopted a positive opinion, recommending the granting of a marketing authorization for the medicinal product Iclusig 15 mg film-coated tablets intended for the treatment of chronic myeloid leukaemia and Philadelphia chromosome positive acute lymphoblastic leukaemia. Iclusig was designated as an orphan medicinal product on March 2, 2010, the EMA noted. The applicant for this medicinal product is ARIAD Pharma. News For ARIA From The Last 14 Days Check below for free stories on ARIA the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 20, 2013 07:34 EDT ARIA UBS to host a conference Subscribe for More Information May 17, 2013 08:22 EDT ARIA ARIAD shares should be bought on weakness, says BMO Capital Subscribe for More Information May 16, 2013 07:29 EDT ARIA Leerink to host a bus tour Boston Biopharma Bus Tour travels throughout Boston on May 16-17. Sign up for a free trial to see the rest of the stories you've been missing.